Chemoradiation With SABR Boost Safe, Effective for Advanced Lung Cancer

TUESDAY, Jan. 16, 2024 -- Chemoradiation with an adaptive stereotactic ablative radiotherapy (SABR) boost is safe and effective for patients with locally advanced, unresectable non–small cell lung cancer (NSCLC), according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news